Showing 381-390 of 7529 results for "".
Clinical Case Report: Severe Allergic Contact Dermatitis of Eyelids: When Topical and Oral Steroids Are Not an Option
https://practicaldermatology.com/topics/general-topics/clinical-case-report-severe-allergic-contact-dermatitis-of-eyelids-when-topical-and-oral-steroids-are-not-an-option/21878/Topical calcineurin inhibitors may present a therapeutic option for contact dermatitis of the eyelids.Take 5: Strategies to Fight Skin Cancer Trends
https://practicaldermatology.com/columns/take-5/take-5-strategies-to-fight-skin-cancer-trends/22035/On the 25th anniversary of the renowned ABCDE's of Melanoma, a contributor to the guidelines shares strategies to improve detection and bolster prevention efforts.New Clinical Guidelines for Nonmelanoma Skin Cancer Treatment; Arctics Biotherapeutics Seeks New FDA Approval for ZORYVE Foam
https://practicaldermatology.com/series/dermwire-tv/new-clinical-guidelines-for-nonmelanoma-skin-cancer-treatment-arctics-biotherapeutics-seeks-new-fda-approval-for-zoryve-foam/26745/In this week’s DermwireTV, new clinical guidelines for nonmelanoma skin cancer treatment; Arcutis Biotherapeutics seeks new FDA approval for ZORYVE foam; Practical Dermatology joins the ReachMD network; and the CEO of SofWave Medical joins us to discuss the company’s Ultrasound technology.The Dermatology and Aesthetics Market: Continued Mergers and Acquisitions Momentum and Emerging Trends
https://practicaldermatology.com/topics/practice-management/the-dermatology-and-aesthetics-market-continued-mergers-and-acquisitions-momentum-and-emerging-trends/23679/The resilience of the dermatology and aesthetics market, coupled with growth opportunities, continues to fuel the M&A trend.Cutaneous Superficial Leiomyosarcoma: A Treatment Conundrum
https://practicaldermatology.com/topics/general-topics/cutaneous-superficial-leiomyosarcoma-a-treatment-conundrum/21504/Select presentations given by dermatology residents at Cosmetic SurgeryDiagnosing Allergic Contact Dermatitis
https://practicaldermatology.com/topics/atopic-dermatitis/diagnosing-allergic-contact-dermatitis/20460/Three cases of ACD reactions to over-the-counter antibiotic ointments.Study Examines Association Between Childhood BMI and Risk of Developing IMSDs
https://practicaldermatology.com/series/dermwire-tv/study-examines-association-between-childhood-bmi-and-risk-of-developing-imsds/27004/In this week's DermwireTV, a new study examines the relationship between childhood BMI and skin diseases; phase 3 data sheds new light on dupilumab’s effect on inflammatory biomarkers in pediatric AD patients; and the president and CEO of Evolus discusses trends in the injectables market.The Impact of Clascoterone Topical Cream, 1%: The US Experience 4 Years After Approval and Clinical Expectations for Acne Patients in Other Regions of the World
https://practicaldermatology.com/topics/acne-rosacea/Impact-Clascoterone-Topical-Cream/32830/Clascoterone topical cream, 1% (Winlevi), approved by the US Food and Drug Administration (FDA) in 2020 as the first novel drug introduced for the treatment of acne vulgaris since 1982, is indicated in the US for patients 12 years of age and older. The safety and efficacy were supported by two succeVtama Approved for AD in Adults and Children
https://practicaldermatology.com/series/dermwire-tv/vtama-approved-ad-adults-and-children/30079/In this week's DermwireTV, the FDA approves Vtama (tapinarof cream 0.1%) for atopic dermatitis in adults and children; the FDA approves Nemluvio (nemolizumab) for moderate-to-severe AD; and the president of Nuance Medical discusses the acquisition of scar treatment brand, Biocorneum.Dr. Battle on Skin of Color Update and Minimizing, Treating Complications from Energy-Based Devices
https://practicaldermatology.com/topics/skin-of-color/dr-battle-skin-color-update-and-minimizing-treating-complications-energy-based-devices/28655/Eliot Battle, MD, discusses the growth of Skin of Color Update, minimizing and treating complications when treating patients of skin of color, and integrating energy-based devices into your practice.